Regulatory Resources
The Cancer Clinical Trials Office provides regulatory assistance to Cancer Institute investigators conducting clinical trials.
Investigator Initiated Studies
Standard Operating Procedures
Safety Reporting and Deviations
Regulatory Audits
Regulatory Documents for Trial Activation
| Stanford Anatomic Pathology & Clinical Laboratories Licensure | |
| California Dept. of Health Services Clinical Laboratory License | Expiration Date |
| Stanford Anatomic Pathology & Clinical Laboratories | 03/29/13 |
| Stanford Clinical Laboratory at Hillview | 12/30/13 |
| Clinical Laboratory Improvement Amendments (CLIA) | Expiration Date |
| Stanford Clinical Laboratories | 02/08/13 |
| Stanford Clinical Laboratory at Hillview | 05/17/14 |
| College of American Pathologists (CAP) | Expiration Date |
| Stanford Anatomic Pathology & Clinical Laboratories | 10/23/14 |
| Stanford Clinical Laboratory at Hillview | 10/23/14 |
| Form FDA 1572 – Statement of Investigator | |
| Form FDA 1572, Statement of Investigator | |
| Form FDA 1572, Frequently Asked Questions | |
Trial Administration